The Weekly Whiskey 01/19/2025
Full version can be found on Dread: https://dreadytofatroptsdj6io7l3xptbet6onoyno2yv7jicoxknyazubrad.onion/post/a9fa8a5deb3a54b33fb7 Tor browser is required to access any .onion links. 🦸 ✅ SUPERLIST MARKETS ✅ – /d/DarkMatterMarket – /d/DarkMatterMarket/wiki?id=0b1527ca – /d/Drughub – /d/DrugHub/wiki?id=45b4b777 – /d/TorZonMarket – /d/TorZonMarket/wiki?id=bb45a6f9 – /d/BlackOps – /d/BlackOps/wiki?id=f3947ea5 ❤️ WHAT’S HAPPENING ON DREAD? ❤️ Bug fix update now live /post/db1372f14a005e67bc16 New Release: Tor Browser 15.0.4 […]
This Is How GLP-1 Drugs Are Forcing Restaurant Chains to Change Their Menus
Weight loss drugs like Wegovy and Zepbound are causing chains to rethink their offerings.
Weight Loss Drugs Could Save Airlines Hundreds of Millions of Dollars, Here’s Why…
PULSE POINTS WHAT HAPPENED: Airlines may see cost savings on fuel if weight loss drugs contribute to lighter passengers, according to a Jefferies Research Services analysis. WHO WAS INVOLVED: Jefferies Research Services, major U.S. airlines including American, Delta, Southwest, and United, and weight loss drug manufacturers. WHEN & WHERE: The analysis comes as weight loss […]
Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus – NBC News
Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus NBC News ‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter appetites and higher costs Fox Business How GLP-1 weight-loss drugs are changing Connecticut’s food scene CT Insider Smaller portions, fewer second drinks: How restaurateurs are adapting to changing consumer trends Inquirer.com Celebrity chef […]
Is Novo Nordisk’s Oral Wegovy Driving Strong Early US Demand Already?
Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January U.S. launch of the oral version of its blockbuster GLP-1 therapy, Wegovy (semaglutide). The pill, approved in late December for obesity and cardiovascular risk reduction, is reportedly seeing robust initial demand, […]
Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders
Post Content
Ozempic no replacement for willpower when it comes to weight loss
A new meta-study — a study of studies — reveals an inconvenient truth about weight loss itself: Willpower still matters. Manufacturers of GLP-1 injectables like Wegovy and Ozempic would prefer we forget that, since forgetting it is profitable. The counter-claim — that diets and exercise are no match for our genes and environment — is […]
Unexpected GLP-1 Side Effect? Cheaper Airline Tickets
The weight loss drug boom could drive fuel costs down.
This dangerous condition can sneak up on you — how GLP-1 drugs can help
More than 1 in 3 US adults has this condition, and most aren’t aware of it.
The ‘biohacking’ trend that has tech workers experimenting on themselves
In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration. These […]